GIP and type 2 diabetes mellitus: The effect of the incretin hormones GLP-1 and GIP to promote pancreatic β-cell function is exploited by an expansive menu of incretin mimetics for the treatment of type 2 diabetes (T2D); however, the incretin effect is well known to diminish as T2D progresses.